Table 1.
Comparing HR-HPV Persistence Across HIV Status
| HIV Positive n (%) |
HIV Negative n (%) |
p – value a | ||
|---|---|---|---|---|
| 6 Month Follow-up | ||||
| All HR-HPV | Persistent | 16 (33%) | 7 (21%) | p = 0.23 |
| Cleared | 33 (67%) | 27 (79%) | ||
| HPV16 or 18 | Persistent | 4 (40%) | 2 (29%) | p = 0.63 |
| Cleared | 6 (60%) | 5 (71%) | ||
| Non-Vaccine HR-HPV | Persistent | 12 (40%) | 5 (29%) | p = 0.26 |
| Cleared | 27 (60%) | 22 (71%) | ||
| 12 Month Follow-up | ||||
| All HR-HPV | Persistent | 9 (31%) | 1 (4%) | p = 0.01 |
| Cleared | 20 (69%) | 24 (96%) | ||
| HPV16 or 18 | Persistent | 3 (38%) | 0 (0%) | p = 0.07 |
| Cleared | 5 (63%) | 7 (100%) | ||
| Non-Vaccine HR-HPV | Persistent | 6 (29%) | 1 (6%) | p = 0.06 |
| Cleared | 15 (71%) | 17 (94%) | ||
a
p-values based on Pearson χ2 with 1 degree of freedom (2 × 2 analyses).